Vimarsana
Biggest News Aggregation in the World

See Medicare Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from See Medicare Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In See Medicare Program Today - Breaking & Trending Today

OIG Enhanced Review: OIG to Investigate the Life Cycle of Managed Care Contracts | Venable LLP - Vimarsana News

OIG Enhanced Review: OIG to Investigate the Life Cycle of Managed Care Contracts | Venable LLP

In August 2023, the Office of Inspector General for the Department of Health and Human Services (OIG) announced a new strategic plan to investigate the life cycle of Medicare Advantage...

A Proposed New Regulatory Environment for Medicare Hospice Providers: Application of the 36-Month Rule, Increasing Enrollment Screening Processes, Informal Dispute Resolution, and Special Focus Designations | Venable LLP - Vimarsana News

A Proposed New Regulatory Environment for Medicare Hospice Providers: Application of the 36-Month Rule, Increasing Enrollment Screening Processes, Informal Dispute Resolution, and Special Focus Designations | Venable LLP

On July 10, 2023, the Centers for Medicare & Medicaid Services (CMS) published a proposed rule (Proposed Rule) that would (i) include hospices in the 36-month rule ownership transfer...

TAKE TWO: CMS's Second Attempt to Streamline Breakthrough Device Coverage Limited to 5 Devices Per Year | Epstein Becker & Green - Vimarsana News

TAKE TWO: CMS's Second Attempt to Streamline Breakthrough Device Coverage Limited to 5 Devices Per Year | Epstein Becker & Green

On June 22, 2023, the Centers for Medicare & Medicaid Services (CMS) announced its proposed “Transitional Coverage for Technologies” (TCET) pathway—the Biden administration’s highly...

CMS's Initial Guidance on Medicare Drug Price Negotiation Program Suggests Familiar Pharmacy Chargeback Process | Epstein Becker & Green - Vimarsana News

CMS's Initial Guidance on Medicare Drug Price Negotiation Program Suggests Familiar Pharmacy Chargeback Process | Epstein Becker & Green

The Centers for Medicare & Medicaid Services (CMS) recently issued initial guidance on how the agency expects the Medicare Drug Price Negotiation Program (the “Negotiation Program”) to...

FTC's PBM Study Signals Broader Federal Scrutiny of the Prescription Drug Sector | Epstein Becker & Green - Vimarsana News

FTC's PBM Study Signals Broader Federal Scrutiny of the Prescription Drug Sector | Epstein Becker & Green

On June 7, 2022, the Federal Trade Commission (FTC) unanimously voted to initiate a study into how business practices employed by some pharmacy benefit managers (PBMs) may impact...